Edesa Biotech Inc.

EDSA | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.11

-$0.03 (-0.72%)

At close: Sep 21, 2026, 4:00 PM ET

$4.11

$0 (0.00%)

After-hours: Sep 21, 2026, 7:48 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-0.72%

(1D)

Rating

Updated: Sep 2, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $39.59M

1D Range

3.99 4.24

52W Range

0.72 20.32

Valuation (TTM)

PE -2.42

PB 3.11

EV/EBITDA -2.05

Valuation (NTM)

Forward PE N/A

Forward PEG -0.61

Price Target $5

Cash Flow

FCF Yield -22.6%

SBC Adj. FCF Yield -23.6%

SBC Impact -4.5%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y 150.0% | 84.1%

Dil EPS 3Y | 5Y 14.6% | 47.8%

FCF 3Y | 5Y -25.3% | 0.1%

Returns

ROA -110.8%

ROE -124.2%

ROIC -166.0%

Financial Health

Net Cash

$10.33M

Current Ratio 2.76

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Edesa Biotech, Inc. is a biopharmaceutical firm focused on discovering, developing, and commercializing clinical-stage treatments for inflammatory and immune system disorders where current medical opt...

Sector Healthcare

Industry Biotechnology

Employees 17

IPO Date Jun 20, 2010

Website www.edesabiotech.com

Fiscal Year October - September

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

+21.65%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞